GAP3KO sporozoites

GAP3KO attenuated Plasmodium falciparum sporozoites · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GAP3KO sporozoites, covering 2025-02-24 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO Sporozoites [Phase 1]

See pricing